Skip to main content

Pharmacokinetics, efficacy, and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass

Publication ,  Conference
Li, JS; Sanders, SP; Perry, AE; Stinnett, SS; Darling, EM; Ungerleider, RM; Jaggers, J; Bokesch, P; Wheeler, A; Anderson, PAW
Published in: CIRCULATION
October 31, 2000

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 31, 2000

Volume

102

Issue

18

Start / End Page

599 / 599

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, J. S., Sanders, S. P., Perry, A. E., Stinnett, S. S., Darling, E. M., Ungerleider, R. M., … Anderson, P. A. W. (2000). Pharmacokinetics, efficacy, and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass. In CIRCULATION (Vol. 102, pp. 599–599). LIPPINCOTT WILLIAMS & WILKINS.
Li, J. S., S. P. Sanders, A. E. Perry, S. S. Stinnett, E. M. Darling, R. M. Ungerleider, J. Jaggers, P. Bokesch, A. Wheeler, and P. A. W. Anderson. “Pharmacokinetics, efficacy, and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass.” In CIRCULATION, 102:599–599. LIPPINCOTT WILLIAMS & WILKINS, 2000.
Li JS, Sanders SP, Perry AE, Stinnett SS, Darling EM, Ungerleider RM, et al. Pharmacokinetics, efficacy, and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. 599–599.
Li, J. S., et al. “Pharmacokinetics, efficacy, and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass.” CIRCULATION, vol. 102, no. 18, LIPPINCOTT WILLIAMS & WILKINS, 2000, pp. 599–599.
Li JS, Sanders SP, Perry AE, Stinnett SS, Darling EM, Ungerleider RM, Jaggers J, Bokesch P, Wheeler A, Anderson PAW. Pharmacokinetics, efficacy, and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. 599–599.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 31, 2000

Volume

102

Issue

18

Start / End Page

599 / 599

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology